Aptus Pharma Board Approves Authorized Capital Increase and 3:2 Bonus Issue
Aptus Pharma Limited's board meeting on March 24, 2026, resulted in approval of authorized share capital enhancement from ₹7.15 crores to ₹25 crores and recommendation of 3:2 bonus equity shares issue. The company will capitalize ₹10.29 crores from securities premium account to issue 1,02,90,000 bonus shares, transforming paid-up capital from ₹6.86 crores to ₹17.15 crores, with CDSL appointed for e-voting process.